The global custom synthesis and manufacturing  market was valued at US$271.33 billion in 2022. The  market value is expected to reach US$474.94 billion  by 2028.

Custom Synthesis and Manufacturing (CSM) is on  the rise across the world, driven by strong growth in  end-use demand, innovators shifting focus to core  competencies and outsourcing of production to low  manufacturing cost destinations.

The CSM market is expected to continue to grow  due to the increasing demand for pharmaceuticals,  growing complexity of drugs, advancements in  technology, increasing patent expiry, and growing  trend of green manufacturing. The market is  expected to grow at a CAGR of approx. 10% during  the forecasted period of 2023-2028.

The global custom synthesis and manufacturing  market growth is predicted to be supported by  numerous growth drivers such as the growing  pharmaceutical industry, rising agrochemical  industry growth, surging cases of cancer, escalating  pharma research and development spending,  increasing demand for specialty chemicals,  increasing regulatory compliance requirement,  increasing outsourcing trend, and many other  factors. There are several regulatory compliance  requirements that chemical and drug manufacturers  must follow to ensure the safety and efficacy of their  products.

The market is projected to grow at a fast pace  during the forecast period, due to various latest  trends such as integration of AI/MI, increasing  patent expiry, technological advancement, green  manufacturing, increasing role of automation and  robotics, etc.

The market is projected to grow at a fast pace  during the forecast period, due to various latest  trends such as integration of AI/MI, increasing  patent expiry, technological advancement, green  manufacturing, increasing role of automation and  robotics, etc.

When a drug or chemical’s patent expires, it  opens up opportunities for generic drug  manufacturers and other companies to produce  and sell the same drug or chemical. This often  leads to increased competition, which in turn  drives down the price of the drug or chemical. As  a result, many pharmaceutical and chemical  companies are increasingly turning to custom  synthesis and manufacturing services to reduce  costs and increase efficiency.

Reference:

https://www.globenewswire.com/news-  release/2023/04/26/2654790/0/en/Global-Custom-  Synthesis-Manufacturing-Market-to-2028-  Increasing-Regulatory-Compliance-Requirement-  Fuels-the-Sector.html

https://www.researchandmarkets.com/reports/578  0848/global-custom-synthesis-and-manufacturing-  csm

More News
Empowering Healthcare Together – The science of biologics meets the strength of distribution
News · 01/07/2025

We’re thrilled to announce a new strategic alliance between ExSyn, Exim-Indis and simABs, a leading EU-based biologics manufacturer known for its patented continuous flow technology in antibody production.

READ MORE
U.S. Tariffs Update – May 2025!
News · 02/06/2025

The global trade landscape is undergoing significant changes following the announcement of new reciprocal tariffs by the United States government. Recent developments indicate significant shifts in global trade dynamics, with key policy adjustments, ongoing negotiations, and evolving logistics patterns. Below is a summary of the latest developments.

READ MORE
Major Regulatory Changes in 2025
News · 02/05/2025

In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.

READ MORE
Technologies And Strategies Reshaping Regulatory Trends
News · 02/05/2025

The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.

READ MORE
Biomanufacturing proliferates in chemicals
News · 31/03/2025

In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?

READ MORE
New Trump tariffs worry North American chemical industries
News · 31/03/2025

High duties on imports from Canada, Mexico and China raise problems for international supply chains.

READ MORE
Advanced Drug Delivery Systems
News · 01/03/2025

Advanced Drug Delivery Systems Market, valued at USD 234.84 billion in 2023, is on a trajectory of significant growth, projected to reach USD 352.01 billion by 2032

READ MORE
US FDA Bans Food Dye Red No.3
News · 01/03/2025

The U.S. Food and Drug Administration on January 15, 2025, announced its decision to ban Red Dye No. 3 also referred to as Erythrosine.

READ MORE
Emerging Trends in Microsphere Technology
News · 01/02/2025

Targeted drug delivery revolutionises treatment by focusing medications on specific tissues, reducing the impact on healthy cells. Scientists enhance this precision with carriers like microspheres and nanoparticles, controlling release and absorption. Microspheres, made from biodegradable proteins or polymers, sustain drug release, making them ideal for targeted therapies, especially in oncology. Beyond drug delivery, microspheres open new possibilities across industries—from next-gen coatings to thermal insulation. With tailored sizes, shapes, and materials, they drive advancements in pharmaceuticals, advanced materials, and more.

READ MORE